We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Elanco Animal Health (ELAN) Q1 Earnings: Wall Street Forecasts for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Elanco Animal Health Incorporated (ELAN - Free Report) will report quarterly earnings of $0.26 per share in its upcoming release, pointing to a year-over-year decline of 42.2%. It is anticipated that revenues will amount to $1.17 billion, exhibiting a decline of 6.6% compared to the year-ago quarter.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Elanco Animal Health metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Total Pet Health' stands at $616.09 million. The estimate indicates a change of -8.7% from the prior-year quarter.
Analysts predict that the 'Revenue- Total Farm Animal' will reach $552.00 million. The estimate indicates a year-over-year change of -3.7%.
Analysts expect 'Revenue- Total Contract Manufacturing' to come in at $8.03 million. The estimate indicates a change of -10.8% from the prior-year quarter.
Over the past month, shares of Elanco Animal Health have returned -13.1% versus the Zacks S&P 500 composite's -1.6% change. Currently, ELAN carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Elanco Animal Health (ELAN) Q1 Earnings: Wall Street Forecasts for Key Metrics
Wall Street analysts forecast that Elanco Animal Health Incorporated (ELAN - Free Report) will report quarterly earnings of $0.26 per share in its upcoming release, pointing to a year-over-year decline of 42.2%. It is anticipated that revenues will amount to $1.17 billion, exhibiting a decline of 6.6% compared to the year-ago quarter.
The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Elanco Animal Health metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Total Pet Health' stands at $616.09 million. The estimate indicates a change of -8.7% from the prior-year quarter.
Analysts predict that the 'Revenue- Total Farm Animal' will reach $552.00 million. The estimate indicates a year-over-year change of -3.7%.
Analysts expect 'Revenue- Total Contract Manufacturing' to come in at $8.03 million. The estimate indicates a change of -10.8% from the prior-year quarter.
View all Key Company Metrics for Elanco Animal Health here>>>
Over the past month, shares of Elanco Animal Health have returned -13.1% versus the Zacks S&P 500 composite's -1.6% change. Currently, ELAN carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>